Proteomic Aging Clocks Enter the Clinic in Landmark Phase 2a Geroprotection Trial
Proteomic aging clocks have been integrated into a phase 2a clinical trial, enabling simultaneous assessment of geroprotective effects within an ...
Proteomic aging clocks have been integrated into a phase 2a clinical trial, enabling simultaneous assessment of geroprotective effects within an ...
Reframing the global disease burden by age reveals that aging-related conditions now dominate in every income group and uniquely offer ...
Telomerase reverse transcriptase (TERT) is moving to the center of aging research, framed by a new Perspective by Richard DePinho ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine